Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma

Transplantation Proceedings

Volumn 44, Issue 9, 2012, Pages 2669-2672

  Vergara Chozas, J M ^a   Saez Benito Godino A ^a   Zopeque Garcia N ^a   Garcia Pinteno S ^a   Joumady, I ^a   Carrasco Garcia C ^a   Vara Gil, F ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACCURACY; BLOOD SAMPLING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENZYME IMMUNOASSAY; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; PARTICLE ENHANCED TURBIDIMETRIC INHIBITION IMMUNOASSAY; PRIORITY JOURNAL; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; DRUG MONITORING; HUMANS; IMMUNOASSAY; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MYCOPHENOLIC ACID; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS, ENTERIC-COATED;

EID: 84869021518     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.09.063     Document Type: Conference Paper

References (16)

1. L.M. Shaw, A. Nicholls, M. Hale Therapeutic monitoring of mycophenolic acid a consensus panel report Clin Biochem 31 1998 317
2. M.D. Wavamunno, J.R. Chapman Individualization of immunosuppression: concepts and rationale Curr Opin Organ Transplant 13 2008 604
3. W. Irish, S. Arcona, R.J. Gifford Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppression: outcome analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network Database Transplantation 90 2010 23
4. K. Buddek, P. Glander, B.K. Krämer Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes Transplantation 83 2007 417
5. J.T. Ranson Mechanism of action of mycophenolate mofetil Ther Drug Monit 17 1995 681
6. +T cell: more than mere guanine nucleotide deprivation Am J Transplant 11 2011 439
7. T.H. Mathews Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years Transplantation 65 1998 1450
8. J.A. Kobashigawa, D.G. Renlund, G. Gerosa Similar efficacy and safety of enteric-coated mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, singler-blind, randomized, parallel-group, multicenter study J Heart Lung Transplant 25 2006 935
9. H. Ekberg, J. Grinyó, B. Nashan Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR study Am J Transplant 7 2007 560
10. R. Venkataramanan, L.M. Shaw Therapeutic monitoring of mycophenolic acid in liver transplant patients Liver Transplant 10 2004 503
11. D. Capone, G. Tarantino, I. Kadilli Evaluation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine Nephrol Dial Transplant 26 2011 3019
12. H. Muller, S. Solari, C. Ziniga Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy Transplant Proc 39 2007 596
13. J.M. Bland, D.G. Altman Statistical method for assessing agreement between two methods of clinical measurement Lancet 327 1986 307
14. M. Shipkova, W. Armstrong, T. Schneider Stability of mycophenolic acid and glucuronide in human plasma Clin Chem 45 1999 127
15. E. Schütz, M. Shipkova, W. Armstrong Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites Transplant Proc 30 1998 1185
16. H. Hosotsubo, S. Takahara, R. Imamura Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay Ther Drug Monit 23 2001 669